DAX23.779 +0,2%ESt505.518 +0,3%Top 10 Crypto15,77 +2,9%Dow46.181 -0,1%Nas22.624 +0,6%Bitcoin97.247 +1,5%Euro1,1732 +0,3%Öl67,89 -2,7%Gold3.827 +1,7%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 DroneShield A2DMAA RENK RENK73 Lufthansa 823212 NVIDIA 918422 Novo Nordisk A3EU6F HENSOLDT HAG000 Tesla A1CX3T Siemens Energy ENER6Y BYD A0M4W9 Deutsche Telekom 555750 Mercedes-Benz Group (ex Daimler) 710000 SAP 716460 Allianz 840400 BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX etwas fester -- US-Börsen uneins -- Lufthansa: Restrukturierung und drohende Streiks -- MoonLake, Palantir, Intel, Canopy Growth, D-Wave & Co., Novo Nordisk, Occidental, DroneShield, BYD im Fokus
Top News
Auf dem Verkaufszettel: Diese Aktien empfehlen Experten zu verkaufen Auf dem Verkaufszettel: Diese Aktien empfehlen Experten zu verkaufen
So bewegen sich Bitcoin & Co. heute So bewegen sich Bitcoin & Co. heute
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Livanova Aktie

Kaufen
Verkaufen
Livanova Aktien-Sparplan
45,60 EUR +1,00 EUR +2,24 %
FSE
52,86 USD -0,57 USD -1,06 %
BTT
Livanova jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.2,49 Mrd. EUR

KGV39,97Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA14156

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINGB00BYMT0J19

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolLIVN

Livanova Aktien News

DatumMeistgelesen
ZacksLivaNova PLC (LIVN) Soars to 52-Week High, Time to Cash Out?
ZacksLivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates
ZacksAre Options Traders Betting on a Big Move in LivaNova Stock?
Wer­bungLivanova-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
ZacksLivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
ZacksLivaNova (LIVN) Tops Q4 Earnings Estimates
BusinesswireLivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
BusinesswireRECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression
BusinesswireLivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting
ZacksWall Street Analysts Predict a 37.2% Upside in LivaNova (LIVN): Here's What You Should Know
BusinesswireLivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
BusinesswireLivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
ZacksLivaNova (LIVN) Upgraded to Strong Buy: What Does It Mean for the Stock?
ZacksHow Much Upside is Left in LivaNova (LIVN)? Wall Street Analysts Think 38.2%
ZacksLivaNova (LIVN) Tops Q3 Earnings and Revenue Estimates
BusinesswireLivaNova Appoints Susan Podlogar as a New Director
BusinesswireLivaNova to Announce Third-Quarter 2024 Results
BusinesswireLivaNova to Present at the Baird Global Healthcare Conference
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN
BusinesswireLivaNova to Announce Second-Quarter 2024 Results
BusinesswireLivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
BusinesswireLivaNova to Present at the Goldman Sachs Healthcare Conference
BusinesswireLivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
BusinesswireLivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
BusinesswireLivaNova to Announce First-Quarter 2024 Results
BusinesswireLivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
BusinesswireLivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
BusinesswireLivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
BusinesswireLivaNova to Present at the Barclays Global Healthcare Conference
BusinesswireLivaNova Announces Vladimir A. Makatsaria as CEO and Board Director
BusinesswireLivaNova to Wind Down Advanced Circulatory Support Business Unit
BusinesswireLivaNova to Announce Fourth-Quarter and Full-Year 2023 Results
BusinesswireLivaNova to Present at the Piper Sandler Healthcare Conference
BusinesswireLivaNova to Present at the Stifel and Wolfe Healthcare Conferences
BusinesswireLivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023
BusinesswireLivaNova to Announce Third-Quarter 2023 Results
BusinesswireLivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark
BusinesswireLivaNova to Present at the Baird Global Healthcare Conference

Livanova News

Livanova News: auf dieser Seite finden Sie alle Livanova News und Nachrichten zur Livanova Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Livanova News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Livanova News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.